HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor

Mechanistic description

DNAJB6 specifically recognizes and suppresses amyloidogenic β-sheet conformations shared across tau, α-synuclein, and TDP-43 aggregates. Enhanced DNAJB6 expression or small molecule activators could provide broad-spectrum protection against cross-seeding by disrupting the common structural motifs that enable heterologous nucleation.

Mechanism / pathway

DNAJB6
→
HSP70-HSP40 (DNAJB6) chaperone-mediated amyloid inhibition
→
neurodegeneration

Evidence for (3)

DNAJB6 potently inhibits polyglutamine aggregation and maintains soluble protein conformations

PMID:23064266
HSP70 co-chaperones show specificity for misfolded β-sheet structures across different amyloidogenic proteins

PMID:31358969
DNAJB6 variants are associated with reduced risk of multiple neurodegenerative diseases

PMID:28887542

Evidence against (3)

DNAJB6 overexpression can actually promote tau aggregation in some contexts by interfering with normal proteostasis

PMID:28302677
HSP70 co-chaperones show substrate specificity that may not translate across different amyloidogenic proteins

PMID:30833379
DNAJB6 mutations cause myopathy through gain-of-function mechanisms, suggesting enhanced activity may be harmful

PMID:23064266

Evidence matrix

3 supporting 3 contradicting

53% posterior support

Supporting

DNAJB6 potently inhibits polyglutamine aggregation and maintains soluble protein conformations PMID:23064266
HSP70 co-chaperones show specificity for misfolded β-sheet structures across different amyloidogenic proteins PMID:31358969
DNAJB6 variants are associated with reduced risk of multiple neurodegenerative diseases PMID:28887542

Contradicting

DNAJB6 overexpression can actually promote tau aggregation in some contexts by interfering with normal proteostasis PMID:28302677
HSP70 co-chaperones show substrate specificity that may not translate across different amyloidogenic proteins PMID:30833379
DNAJB6 mutations cause myopathy through gain-of-function mechanisms, suggesting enhanced activity may be harmful PMID:23064266

Top-ranked evidence

trust_score × relevance_score × exp(-recency_weight × recency_days / 365)

Supports · top 3

#1 paper-28a0149c0cb4 0.462 trust 0.50 · rel 1.00 · 95d
#2 paper-bd93f803abb1 0.462 trust 0.50 · rel 1.00 · 95d
#3 paper-bd93f803abb1 0.459 trust 0.50 · rel 1.00 · 104d

32 total ranked · scidex.hypotheses.evidence_ranking

Bayesian persona consensus

53% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-c9486869

BibTeX

@misc{scidex_hypothesis_hc948686,
  title        = {HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-c9486869},
  note         = {SciDEX artifact hypothesis:h-c9486869}
}